Medinotec (MDNC) Cash & Current Investments (2022 - 2026)
Medinotec (MDNC) posted Cash & Current Investments of $2.5 million for Q2 2026, down 8.66% on a QoQ basis from $2.8 million in Q1 2026, and up 29.09% year-over-year from $2.0 million in Q2 2025.
Medinotec (MDNC) Cash & Current Investments (2022 - 2026) Analysis & Trends
Medinotec's Cash & Current Investments history runs 5 years deep, the most recent figure standing at $2.5 million for Q2 2026.
- Quarterly Cash & Current Investments rose 29.09% year-over-year to $2.5 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $2.5 million (up 29.09% YoY) and the FY2026 annual result came in at $2.8 million, changed 0.46% from the prior year.
- Cash & Current Investments was $2.5 million for Q2 2026 at Medinotec, down from $2.8 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $3.6 million in Q2 2022 and bottomed at $131577.0 in Q1 2022.
- A 5-year average of $2.6 million and a median of $2.8 million in 2024 frame the typical range for Cash & Current Investments.
- Peak annual rise in Cash & Current Investments reached 2048.9% in 2023, while the deepest fall reached 23.93% in 2023.
- Medinotec's Cash & Current Investments stood at $2.8 million in 2022, then declined by 5.9% to $2.7 million in 2023, then decreased by 0.08% to $2.7 million in 2024, then increased by 6.74% to $2.9 million in 2025, then dropped by 11.85% to $2.5 million in 2026.
- Business Quant data shows MDNC's Cash & Current Investments at $2.5 million in Q2 2026, $2.8 million in Q1 2026, and $2.9 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | 2.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 2.52 Mn |
| Feb 28, 2026 | 2.76 Mn |
| Nov 30, 2025 | 2.86 Mn |
| Aug 31, 2025 | 2.25 Mn |
| May 31, 2025 | 1.95 Mn |
| Feb 28, 2025 | 2.77 Mn |
| Nov 30, 2024 | 2.68 Mn |
| Aug 31, 2024 | 2.76 Mn |
| May 31, 2024 | 2.52 Mn |
| Feb 29, 2024 | 2.81 Mn |
| Nov 30, 2023 | 2.68 Mn |
| Aug 31, 2023 | 2.84 Mn |
| May 31, 2023 | 2.71 Mn |
| Feb 28, 2023 | 2.83 Mn |
| Nov 30, 2022 | 2.85 Mn |
| Aug 31, 2022 | 3.39 Mn |
| May 31, 2022 | 3.56 Mn |
| Feb 28, 2022 | 131,577.00 |